Ken Fisher
PTLA

Ken Fisher’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Ken Fisher’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-46,245
Closed -$330K – 868
2020
Q1 		$330K Sell
46,245
-83
-0.2% -$1.04K ﹤0.01% 669
2019
Q4 		$1.11M Sell
46,328
-42,739
-48% -$1.18M ﹤0.01% 574
2019
Q3 		$2.39M Sell
89,067
-11,655
-12% -$327K ﹤0.01% 515
2019
Q2 		$2.73M Buy
100,722
+14,338
+17% +$450K ﹤0.01% 499
2019
Q1 		$3M Sell
86,384
-7,308
-8% -$211K ﹤0.01% 471
2018
Q4 		$1.83M Hold
93,692
– – ﹤0.01% 535
2018
Q3 		$2.5M Buy
93,692
+1,848
+2% +$60.3K ﹤0.01% 502
2018
Q2 		$3.47M Sell
91,844
-4,810
-5% -$184K ﹤0.01% 479
2018
Q1 		$3.16M Hold
96,654
– – ﹤0.01% 483
2017
Q4 		$4.71M Buy
96,654
+34,761
+56% +$1.76M 0.01% 430
2017
Q3 		$3.34M Buy
61,893
+15,256
+33% +$896K ﹤0.01% 446
2017
Q2 		$2.62M Hold
46,637
– – ﹤0.01% 449
2017
Q1 		$1.83M Hold
46,637
– – ﹤0.01% 455
2016
Q4 		$1.05M Sell
46,637
-36,100
-44% -$705K ﹤0.01% 505
2016
Q3 		$1.88M Hold
82,737
– – ﹤0.01% 469
2016
Q2 		$1.97M Buy
82,737
+2,437
+3% +$60.2K ﹤0.01% 467
2016
Q1 		$1.93M Hold
80,300
– – ﹤0.01% 469
2015
Q4 		$4.13M Hold
80,300
– – 0.01% 365
2015
Q3 		$3.42M Hold
80,300
– – 0.01% 359
2015
Q2 		$3.66M Hold
80,300
– – 0.01% 357
2015
Q1 		$3.05M Buy
+80,300
New +$2.76M 0.01% 364

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Ken Fisher's PTLA Position: Q2 2020 in Review

Ken Fisher sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 46,245 shares — an estimated $330K sold.

Ken Fisher first reported a position in PTLA in Q1 2015 and held it in 21 quarters. The position peaked at $4.71M in Q4 2017. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • Ken Fisher reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Ken Fisher sold 46,245 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $330K.
  • Ken Fisher first reported a position in Portola Pharmaceuticals, Inc. in Q1 2015 and held it in 21 quarters.
  • Ken Fisher's Portola Pharmaceuticals, Inc. position peaked at $4.71M in Q4 2017.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Fisher Asset Management's 13F filing for Q2 2020, filed 7 Aug 2020.